Curis Lifesciences IPO

Incorporated in 2010, Curis Lifesciences Limited is a pharmaceutical company that specializes in developing, manufacturing, and distributing a diverse range of products. The company manufactures pharmaceutical products globally and domestically on a loan license or contract basis, as well as for its own brand marketing. The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Products: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The company operates a state-of-the-art manufacturing facility in Sanand, Gujarat, adhering to stringent quality control measures to ensure product safety and efficacy. As of July 31, 2025, the company has 95 permanent employees. Competitive Strengths: Experienced Promoters and Management Team Wide range of Products Strategic Location of Manufacturing Facility Scalable Business Model Quality assurance

Capital Expenditure towards Upgradation/Improvement of the existing Manufacturing Facilities Capital Expenditure towards Construction of a Storage Facility Pre-payment/Repayment of outstanding Secured Loans Product Registrations in other countries Funding our Working Capital Requirements General Corporate Purposes